Why get involved?
- With more people being diagnosed with breast cancer each year, more effective treatments are needed.
- Treatments with less side effects are needed so women can experience a better quality of life after a breast cancer diagnosis.
- With more funding we are able to drive more research for better treatment options.
- New exciting treatments that activate the body’s own immune system are providing hope for those affected by breast cancer.
- Extending this research will create new treatments that will improve outcomes and ultimately, save lives.
- With every injection of funds, the pace of research can be accelerated, so that those affected by breast cancer can see the treatment benefits earlier.
"NBCF is proudly 100% community funded. While we acknowledge the importance of government funding across a diverse range of subject areas, from health to politics and the environment, NBCF receives funding directly from the community. That allows us to lead the way, targeting research that will reduce deaths from breast cancer and improve quality of life. This is what the community has asked us to do."
- Professor Sarah Hosking, CEO, NBCF
Working towards zero deaths by 2030
Climbing for Breast Cancer research, will keep our researchers in the lab and on the road to discovery. Providing better treatment to drastically improve the lives of those affected by breast cancer and creating a better tomorrow for those impacted by breast cancer.
Impact of your fundraising
Helps to make treatments more powerful but less toxic to the body so there are less side effects.
Helps to develop next-generation treatments that enable the immune system to attack cancer cells.
Means a woman can take part in a clinical trial to test new treatments for breast cancer.
Helps to keep our young, bright researchers working towards the next big discovery.
Professor Sandra O’Toole
Garvan Institute of Medical Research
Breast cancer researchers face challenges in the current Australian medical research funding landscape. Professor O’Toole’s research is driven by the issues she sees in her clinical job as a pathologist – to further understand the molecular changes in aggressive types of breast cancer to improve decision-making to ensure patients receive exactly the right treatment.
"For me, the support of the National Breast Cancer Foundation means that I can combine clinical work and research which I believe helps push research from the bench to the bedside. I have seen the difference that this support makes, keeping promising researchers working in science and undertaking innovative projects."
Professor Kelly-Anne Phillips
Peter MacCallum Cancer Centre
Prof Kelly-Anne Phillips’ research project will improve our understanding of the genetic and non-genetic factors that affect BC risk, and enhance our ability to predict risk for an individual woman, using data from large international studies. This will result in better targeting of breast cancer prevention and screening strategies.
The project, funded by the National Breast Cancer Foundation, will also enhance breast cancer prevention by developing and testing the web-based “iPrevent” risk assessment and decision aid tool which will help GPs, breast surgeons and other clinicians to accurately assess and effectively manage breast cancer risk.
Professor Nehmat Houssami
University of Sydney
The national breast screening program, by facilitating earlier detection, has contributed to a much improved survival rate for breast cancer. However, although 3D mammograms are available in some private clinics in Australia, they are not backed by enough evidence to show that they provide better outcomes than standard screening.
The main element of this multi-pronged research program, funded by the National Breast Cancer Foundation, aims to improve outcomes for Australian women, including those with dense breast tissue, by ensuring that 3D mammography evidence is available to inform on the most effective screening methods.
The evidence from this research project will prompt decisions on whether 3D mammography should be adopted as a primary screening strategy in Australia and globally sooner rather than later.